TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06058715

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transverse Abdominal Plan block (TAP block)
Description: Bilateral TAP block is administered intraoperatively at laparoscopy, directly after insufflation and insertion of the first trocar and camera. The ultrasound probe is placed longitudinally on the midaxillary line near umbilicus, and the transversus abdominis and internal oblique muscles are scanned and observed. The needle (22-gauge 90 mm disposable spinal needle) is inserted in plane and after placing the needle-tip into the fascia between transversus abdominis and internal oblique muscles, 20 ml of ropivacaine 0.25% is injected bilaterally. It is all done by one Anesthetist which is expert in that area and is not in charge of collecting the data.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transverse Abdominal Plan block (TAP block)
Description: Bilateral TAP block is administered intraoperatively at laparoscopy, directly after insufflation and insertion of the first trocar and camera. The ultrasound probe is placed longitudinally on the midaxillary line near umbilicus, and the transversus abdominis and internal oblique muscles are scanned and observed. The needle (22-gauge 90 mm disposable spinal needle) is inserted in plane and after placing the needle-tip into the fascia between transversus abdominis and internal oblique muscles, 20 ml of ropivacaine 0.25% is injected bilaterally. It is all done by one Anesthetist which is expert in that area and is not in charge of collecting the data.
Study: NCT06546917

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: bWell Cognitive Remediation
Description: Patients will take part in the bWell cognitive remediation protocol, consisting of 40-minute sessions of bWell, administered 2 times a week for 8 weeks. These sessions consist of tasks that target various cognitive domains and increase in complexity and difficulty as training progresses. The tasks are as follows:~1. Lab Exercise: participant alternates between two different, increasingly complex 'recipes', targeting executive functioning and divided attention.~2. Egg Exercise: In an office environment, participants must seek out and maintain their gaze on certain objects in order to collect them in the presence of visual distractors, targeting sustained attention.~3. Mole Exercise: participants must strike moles with the matching coloured hammer as fast as possible, targeting selective attention.~4. Theatre Exercise: participants must remember objects presented on stage and recreate the sequence after the curtains close, targeting working memory.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: VR Experience
Description: Patients will take part in the viewing of VR scenes which contain no instructed cognitive tasks. This consists of 40-minute sessions of viewing VR scenes, administered 2 times a week for 8 weeks.
Study: NCT04990778

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eprenetapopt
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO
Study: NCT04853615

Intervention type: DRUG
Intervention: Empagliflozin 25 MG
Description: PAtient will receive empagliflozin 25 mg daily

Intervention type: DRUG
Intervention: Empagliflozin 25 MG
Description: PAtient will receive empagliflozin 25 mg daily
Study: NCT06509360

Intervention type: DEVICE
Group type: OTHER
Intervention: Feelee app
Description: Adolescents uses the Feelee app for 4-weeks in addition to treatment as usual in the forensic outpatient setting. The use of Feelee involves: submitting one emoji every day and allow the Feelee app to read the following passive data from the health app on the smartphone: number of steps and number of hours of sleep. The collected Feelee data will be presented in a dashboard in the Feelee app itself which will be discussed by the clinician in the weekly treatment session (in case the adolescents agreed to show the Feelee data to the clinician).
Study: NCT05698251

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Uncertainty distress model
Description: Psychological therapy intervention based on elements of traditional Cognitive Behaviour Therapy (CBT) for anxiety, illness uncertainty and intolerance of uncertainty.
Study: NCT06146478

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thalidomide
Description: Thalidomide given at an average dose of 1.5mg/kg/day
Study: NCT02978677

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy 68 Gy(RBE)
Description: Radiotherapy 2.0 to 50 Gy(RBE) photon or proton and boost 2 to 18 Gy(RBE) proton

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy 72 Gy(RBE)
Description: Radiotherapy 2.0 to 50 Gy(RBE) photon or proton and boost 2 to 18 Gy(RBE) proton and boost 2 to 4 Gy(RBE) proton

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiotherapy 60 Gy(RBE)
Description: Radiotherapy 2.0 to 50 Gy(RBE) photon or proton and boost 2 to 10 Gy(RBE) proton
Study: NCT05563389

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin 20mg
Description: active arm

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo arm
Study: NCT04977115

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraocular caliper-assisted capsulotomy
Description: Intraocular caliper is a modified intraocular caliper with standard calibration on the rinse needle.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Verion navigation system-assisted capsulotomy
Description: Verion Image Guided System (Alcon Laboratories, Inc.) is a digital image guidance system consisting of a diagnostic reference unit and a surgery pilot for intraoperative surgical assistance. The device can be used to align toric intraocular lens during surgery as well as support manual creation of a capsulorhexis with a predefined target diameter.
Study: NCT03088774

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Information material
Description: Online web-application developed together with patients with low back pain

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Information material
Description: Online web-application developed together with patients with low back pain
Study: NCT04699942

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional (low flow) oxygen delivery via nasal cannula
Description: Conventional (low flow) oxygen delivery via nasal cannula or face mask for 20 minutes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Revoxa Oxygen Rebrearther
Description: Oxygen delivery via Revoxa Oxygen Rebreather device for 20 minutes
Study: NCT06544356

Intervention type: OTHER
Intervention: No intervention, questionnaire filled out
Description: Mother introductory information form, Health Literacy Scale, Knowledge and Attitude Scale about Newborn Screenings were completed.
Study: NCT05681273

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chiglitazar
Description: Chiglitazar 48mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chiglitazar
Description: Chiglitazar 48mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chiglitazar
Description: Chiglitazar 48mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Description: Empagliflozin 10mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: Atorvastatin 20mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valsartan
Description: Valsartan 160mg
Study: NCT06026475

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Goal directed Fluid Therapy
Description: Patients will receive fluid during surgery with goal of maintaining SVV below 11

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Fluid Therapy
Description: Patients will receive fluid during surgery with goal of maintaining CVP between 8-12 cms H20
Study: NCT00909129

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pegylated interferon-alpha (Pegasys)
Description: Pegylated interferon-alpha 2a 180 micrograms s.c. weekly

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ribavirin (COPEGUS)
Description: ribavirin bid 800-1200 mg depending on HCV genotype and body weight
Study: NCT05575817

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web Based Patient Tutorial on Prolonged Grief Disorder Therapy
Description: The patient tutorial will contain 9 modules, each designed to be used flexibly in conjunction with Prolonged Grief Disorder Therapy (PGDT) telehealth sessions with the therapist. Each module takes about 15-30 minutes to complete. The patient tutorial consists of information about grief and adaptation to loss, including a description of seven healing milestones that are the focus of PGDT and an explanation of prolonged grief and how to understand it. In addition, the tutorial has descriptions of the procedure, goals and rationale for a series of in-session therapeutic exercises to be undertaken with the therapist, as well as descriptions and encouragement to participate in interim therapeutic activities (i.e., homework) assigned by the therapist after each treatment session. The tutorial also contains a self-assessment component for each module that can be completed by the patient and shared with the therapist.
Study: NCT05570305

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan
Description: Zibotentan 1.5 mg once per day as a hard capsule.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan
Description: Zibotentan 1.5 mg once per day as a hard capsule.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Dapagliflozin 10 mg once per day as a tablet.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Dapagliflozin 10 mg once per day as a tablet.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin and Zibotentan
Description: Dapagliflozin 10 mg once per day as a tablet in combination with zibotentan 1.5 mg once per day as a hard capsule.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin and Zibotentan
Description: Dapagliflozin 10 mg once per day as a tablet in combination with zibotentan 1.5 mg once per day as a hard capsule.
Study: NCT05861765

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Papaverine Hydrochloride
Description: Slowly inject 10ml of papaverine hydrochloride solution (30mg/10ml) through the successfully implanted radial artery sheath, and continuously drip papaverine hydrochloride solution (60mg/500ml, 4ml/min) through the artery sheath during the operation. The compatible solutions are normal saline(0.9%);

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: After inserting the radial artery sheath, slowly inject 10ml normal saline(0.9%) through the artery sheath, then continuously drip normal saline(0.9%, 500ml, 4ml/min) through the artery sheath during the operation.
Study: NCT05426993

Intervention type: OTHER
Intervention: Complex decongestive physiotherapy
Description: CDT is a treatment approach consisting of manual lymph drainage, skin care, compression bandage and exercises.

Intervention type: OTHER
Intervention: Complex decongestive physiotherapy
Description: CDT is a treatment approach consisting of manual lymph drainage, skin care, compression bandage and exercises.
Study: NCT05865158

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home-based exercises
Description: Home-based exercises proposed through the CardioSafe+ platform, guided by therapists specialized in cardiovascular disorders, who will try to adapt the sessions to each participant.
Study: NCT05760521

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Provider Educational Intervention
Description: Following the informed consent (10 min) and sociodemographic survey (5 minutes), the providers in Arm A will be offered education of two days, six hours each day, with support and follow-up. They will also be asked to complete brief knowledge and confidence surveys pre-post-intervention (30 minutes total).
Study: NCT05457166

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: KASPARD system for fall prevention in nursing homes
Description: All subjects will be monitored for 2 periods of 100 nights each. Recordings will be made continuously at night for the duration of the study Period 0: set-up, adjustment, recording (without alarm); This is a preparatory phase which is part of the usual use of the device.~Duration: 10 days Before period: The BEFORE period runs for 100 nights during which the device alarm is not activated, but the device records events.~After period: The AFTER period is 100 nights during which the device alarm is activated: Monitoring with recording + alarm activated (usual care + action if alarm is triggered)
Study: NCT06314139

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: continuous theta-burst stimulation (cTBS)
Description: Continuous theta-burst stimulation (cTBS) was performed with a CCY-I Magnetic Stimulator (YIRUIDE Medical Co., Wuhan, China) with an air-cooled, figure-of-eight 70 mm coil. The site of stimulation during the TMS treatment sessions was bilateral M1 and cerebellum. Real cerebellar cTBS was delivered with the coil positioned over the cerebellar hemisphere, i.e., 3 cm laterally to and 1 cm below the inion. The cTBS protocol uses a complex pattern of stimulation consisting of three-pulse bursts at 50 Hz repeated every 200ms. A total of 600 pulses that lasts for about 40 seconds were applied which could result in a sustained reduction in corticospinal excitability that outlasted the period of stimulation by 45 min. It was delivered at an intensity corresponding to 80 % of the active motor threshold (AMT), this is the minimum stimulation intensity that evokes MEPs of approximately 200 μV in amplitude in tonically contracted muscles.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: continuous theta-burst stimulation (cTBS)
Description: Continuous theta-burst stimulation (cTBS) was performed with a CCY-I Magnetic Stimulator (YIRUIDE Medical Co., Wuhan, China) with an air-cooled, figure-of-eight 70 mm coil. The site of stimulation during the TMS treatment sessions was bilateral M1 and cerebellum. Real cerebellar cTBS was delivered with the coil positioned over the cerebellar hemisphere, i.e., 3 cm laterally to and 1 cm below the inion. The cTBS protocol uses a complex pattern of stimulation consisting of three-pulse bursts at 50 Hz repeated every 200ms. A total of 600 pulses that lasts for about 40 seconds were applied which could result in a sustained reduction in corticospinal excitability that outlasted the period of stimulation by 45 min. It was delivered at an intensity corresponding to 80 % of the active motor threshold (AMT), this is the minimum stimulation intensity that evokes MEPs of approximately 200 μV in amplitude in tonically contracted muscles.
Study: NCT06545279

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hall Crown Technique
Description: preformed metal crowns (PMCs) cemented with no local anesthesia, caries removal or tooth preparation.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Modified Hall Technique
Description: preformed metal crowns (PMCs) cemented with no local anesthesia, caries removal or tooth preparation but with interproximal slicing.
Study: NCT04883112

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnetic Tape®
Description: Magnetic tape® is applied without creating any tension over low back

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Kinesiology Tape
Description: Kinesiology tape is applied without creating any tension over low back
Study: NCT06001853

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BM-MSC injection
Description: BM-MSCs at the dose 10 x 106 in 1 ml per facet joint for a total of 2 joints

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: DSMO Injection
Description: After 6 months, patients randomized to Arm B: DMSO will be unblinded and re-assigned to Arm A: treatment then be followed for 12 months.
Study: NCT05811299

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Description: Total of 8 sessions for 4 weeks 2 sessions in a week.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Abominal exercises
Description: Total of 8 sessions for 4 weeks 2 sessions in a week.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Abominal exercises
Description: Total of 8 sessions for 4 weeks 2 sessions in a week.
Study: NCT06077903

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GT101
Description: Autologous tumor infiltrating lymphocyte injection
Study: NCT05196282

Intervention type: OTHER
Intervention: Smoking cessation
Description: Patients are forced to stop smoking

Intervention type: OTHER
Intervention: Smoking cessation
Description: Patients are forced to stop smoking

Intervention type: OTHER
Intervention: Smoking cessation
Description: Patients are forced to stop smoking

Intervention type: OTHER
Intervention: Smoking cessation
Description: Patients are forced to stop smoking

Intervention type: OTHER
Intervention: Smoking cessation
Description: Patients are forced to stop smoking

Intervention type: OTHER
Intervention: Smoking cessation
Description: Patients are forced to stop smoking
Study: NCT05808296

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lavander oil Aromatherapy
Description: Lavander oil Aromatherapy

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Saline Solution
Description: Saline solution application
Study: NCT06035081

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisolone
Description: see arm description

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisolone
Description: see arm description

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo similar to prednisolone
Study: NCT05424354

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Altrazeal (R) Transforming Powder Dressing
Description: After informed consent and the subject is determined to meet all selection criteria, randomization will occur in a 1:1 ratio, to determine the treatment arm of the study. Half of those randomized will receive burn care with Altrazeal TPD.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care burn dressing
Description: After informed consent and the subject is determined to meet all selection criteria, randomization will occur in a 1:1 ratio, to determine the treatment arm of the study. Half of those randomized will receive burn care with the institution's standard of care burn dressing.
Study: NCT06035081

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo similar to prednisolone
Study: NCT06370442

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Intranasal dexmedetomidine, 100mcg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lorazepam
Description: 0.5mg IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Haloperidol
Description: 0.5mg IV
Study: NCT06026930

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low-level laser therapy
Description: LLLT and LIPUS has been found to speed up OTM by stimulating the RANK/RANKL/OPG system to initiate osteoclast formation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low-level laser therapy
Description: LLLT and LIPUS has been found to speed up OTM by stimulating the RANK/RANKL/OPG system to initiate osteoclast formation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low-level laser therapy
Description: LLLT and LIPUS has been found to speed up OTM by stimulating the RANK/RANKL/OPG system to initiate osteoclast formation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low-level laser therapy
Description: LLLT and LIPUS has been found to speed up OTM by stimulating the RANK/RANKL/OPG system to initiate osteoclast formation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low-level laser therapy
Description: LLLT and LIPUS has been found to speed up OTM by stimulating the RANK/RANKL/OPG system to initiate osteoclast formation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low-level laser therapy
Description: LLLT and LIPUS has been found to speed up OTM by stimulating the RANK/RANKL/OPG system to initiate osteoclast formation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low-level laser therapy
Description: LLLT and LIPUS has been found to speed up OTM by stimulating the RANK/RANKL/OPG system to initiate osteoclast formation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low-level laser therapy
Description: LLLT and LIPUS has been found to speed up OTM by stimulating the RANK/RANKL/OPG system to initiate osteoclast formation.
Study: NCT05741190

Intervention type: DEVICE
Intervention: Pentacam Imaging
Description: Imaging of the corneal surface

Intervention type: DEVICE
Intervention: Pentacam Imaging
Description: Imaging of the corneal surface

Intervention type: DEVICE
Intervention: Pentacam Imaging
Description: Imaging of the corneal surface
Study: NCT04967898

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bowen technique
Description: Bowen technique is a soft tissue mobilization technique. This medical care involves short mild rolling moves over the muscles, nerves, ligaments, and tendons of flesh utilizing the hands, fingers and thumb. Sequence of receiving bilateral rolling moves over segments of the erector spinae from the lumber toward cervical spine, latissimus dorsi, the gluteal, the hamstring muscles proximally and distally, tensor facia Lata and a medial hip striated muscle move.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: sustained stretching
Description: static stretching is one of the most common and safest technique used for hamstring tightness. A static stretch is performed by inserting muscles at their greatest attainable length and holding that position for an amount of your time.